The findings suggest the critical role of MMP8 in sepsis and its potential as a promising biomarker of sepsis-induced pulmonary vascular leakage and its potential as a promising biomarker of pleural effusion risk.
Abstract
Endothelial dysfunction is a major contributor to multi-organ failure and mortality in sepsis, with the lungs being particularly susceptible to vascular leakage. Previous studies have implicated matrix metalloproteinase 8 (MMP8) in sepsis pathogenesis. However, the role of MMP8 in maintaining endothelial barrier integrity during sepsis remains unclear. This study aimed to investigate the role of MMP8 in sepsis-induced vascular leakage and the underlying mechanisms. A significant increase in MMP8 expression was observed in lipopolysaccharide (LPS)-treated endothelial cells and lung tissues from mice with cecum ligation and puncture-induced sepsis. In vitro, loss- or gain-of-function of MMP8 in endothelial cells modulated LPS- or Cytomix (TNF-α, IL-1β and IFN-γ)-induced endothelial hyperpermeability, without inducing cell apoptosis or affecting cell viability. In vivo, pharmacologic inhibition of MMP8 alleviated pulmonary vascular leakage, multi-organ injury, and mortality in septic mice. Mechanistically, MMP8 interacted with ERK, promoting its phosphorylation, and consequently activated calpains, leading to membrane VE-cadherin proteolysis. This induced VE-cadherin internalisation through clathrin- and caveolin 1-mediated endocytosis. Clinically, serum MMP8 levels were elevated in patients with sepsis, with the highest levels observed in those with pleural effusion. A nomogram incorporating albumin, blood urea nitrogen, lactate, Acute Physiology and Chronic Health Evaluation II score, and serum MMP8 levels showed favourable prediction accuracy and clinical utility for pleural effusion risk. These findings suggest the critical role of MMP8 in sepsis and its potential as a promising biomarker of sepsis-induced pulmonary vascular leakage.
It is suggested that MYR alleviates septic endothelial barrier disruption and MODS, at least in part, by suppressing PAR1-associated NF-κB/NLRP3-mediated endothelial pyroptosis.
Linjun Zhao, Long Zheng, Jiahui Hu et al.· International Immunopharmaco...· 0 citations
It is suggested that DPEP1 may promote NF-κB activation in an EGR1-dependent manner, thereby enhancing inflammatory signaling in endothelial cells in sepsis-associated endothelial cells.
B. Lin, Xin-Hua Xian, Rong-Juan Huang et al.· International Journal of Gen...· 0 citations
Endothelial dysfunction underpins the pathogenesis of sepsis-induced acute lung injury (SI-ALI), wherein neutrophil extracellular traps (NETs) serve as pivotal mediators driving excessive inflammatory responses and progressive tissue deterioration. This study aimed to elucidate the molecular mechanism by which NETs dis...
Sepsis-associated acute lung injury (SALI) is a critical complication of sepsis, characterized by alveolar epithelial barrier disruption and excessive inflammation, which contributes substantially to morbidity and mortality. The present study investigates the protective effects of ginsenoside Rb1 on SALI and elucidates...
Ming Hao, Yun-Yan Zhang, Liu Chen et al.· International Immunopharmaco...· 0 citations
OBJECTIVE
To investigate the mechanism by which Intermittent Hypoxia (IH) promotes Pulmonary Arterial Hypertension (PAH), focusing on ROS-NLRP3 inflammasome-mediated endothelial cell pyroptosis.
METHODS
Human Pulmonary Microvascular Endothelial Cells (HPMECs) and a monocrotaline-induced PAH rat model were exposed to...